ImmuneOncia immuneoncia.com


Public lists: Pharma Startups (6570)

ImmuneOncia seeks to develop and commercialize a number of immune checkpoint antibodies against undisclosed targets for both hematological malignancies and solid tumors.

ImmuneOncia seeks to develop and commercialize a number of immune checkpoint antibodies against undisclosed targets for both hematological malignancies and solid tumors.

Company (Alive / Active)

All investors data 3 Investors

Phone: +82 (31) 306-8186

Fax:

25, Tapsil-ro 35 road
Giheung-gu, Yongin-si
 Gyeonggi-do, 17084
 South Korea

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImmuneOncia $40M Feb 12, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImmuneOncia Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)